Physician profile
Jacob Rosenstein
NPI 1376548396
$40,020.63
in general payments reported to CMS, 2019-2025
14 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2021: $13.99 · 2022: $22.98 · 2024: $80.22 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $39,500.00 | 2019 | |
| Osseus Fusion Systems, LLC | $130.57 | 2019 | |
| Orthofix Medical, INC. | $63.46 | 2019 | |
| Ethicon US, LLC | $59.57 | 2025 | Vistaseal |
| Medacta USA, INC. | $57.28 | 2024 | |
| Centinel Spine, LLC | $47.04 | 2025 | Prodisc C Vivo |
| Baxter Healthcare | $29.91 | 2019-2021 | |
| Abbott Laboratories | $22.98 | 2022 | |
| Ibsa Pharma INC. | $22.94 | 2024 | Licart, Tirosint |
| Boston Scientific Corporation | $19.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.54 | 2025 | Exparel |
| Vertical Pharmaceuticals, LLC | $17.89 | 2019 | |
| Pfizer INC. | $17.46 | 2019 | |
| Assertio Therapeutics, INC. | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Rosenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.